Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

Darius Armstrong-James; Jonathan Youngs; Tihana Bicanic; Alireza Abdolrasouli; David W Denning; Elizabeth Johnson; Varun Mehra; Tony Pagliuca; Brijesh Patel; Johanna Rhodes; Silke Schelenz; Anand Shah; Frank L van de Veerdonk; Paul E Verweij; P Lewis White; Matthew C Fisher

doi:10.1183/13993003.02554-2020

Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

Darius Armstrong-James
, Jonathan Youngs
, Tihana Bicanic
, Alireza Abdolrasouli
, David W Denning
, Elizabeth Johnson
, Varun Mehra
, Tony Pagliuca
, Brijesh Patel
, Johanna Rhodes
, Silke Schelenz
, Anand Shah
, Frank L van de Veerdonk
, Paul E Verweij
, P Lewis White
, Matthew C Fisher

Biosciences

Research output: Contribution to journal › Article › peer-review

Abstract

Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections https://bit.ly/3feuGsQ

Original language	English
Journal	The European respiratory journal
Volume	56
Issue number	4
DOIs	https://doi.org/10.1183/13993003.02554-2020
Publication status	Published - Oct 2020

Keywords

Adrenal Cortex Hormones/therapeutic use
Antifungal Agents/therapeutic use
Betacoronavirus
Bronchoalveolar Lavage Fluid/microbiology
Bronchoscopy
COVID-19
Coinfection/diagnosis
Coronavirus Infections/drug therapy
Humans
Immunologic Factors/therapeutic use
Intensive Care Units
Invasive Pulmonary Aspergillosis/diagnosis
Pandemics
Pneumonia, Viral/drug therapy
Pulmonary Aspergillosis/diagnosis
Risk Factors
SARS-CoV-2
Ventilation
COVID-19 Drug Treatment

Access to Document

10.1183/13993003.02554-2020

Cite this

Armstrong-James, D., Youngs, J., Bicanic, T., Abdolrasouli, A., Denning, D. W., Johnson, E., Mehra, V., Pagliuca, T., Patel, B., Rhodes, J., Schelenz, S., Shah, A., van de Veerdonk, F. L., Verweij, P. E., White, P. L., & Fisher, M. C. (2020). Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. The European respiratory journal, 56(4). https://doi.org/10.1183/13993003.02554-2020

@article{429659842d6c44cd94f1b599e6f2a75a,

title = "Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis",

abstract = "Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections https://bit.ly/3feuGsQ",

keywords = "Adrenal Cortex Hormones/therapeutic use, Antifungal Agents/therapeutic use, Betacoronavirus, Bronchoalveolar Lavage Fluid/microbiology, Bronchoscopy, COVID-19, Coinfection/diagnosis, Coronavirus Infections/drug therapy, Humans, Immunologic Factors/therapeutic use, Intensive Care Units, Invasive Pulmonary Aspergillosis/diagnosis, Pandemics, Pneumonia, Viral/drug therapy, Pulmonary Aspergillosis/diagnosis, Risk Factors, SARS-CoV-2, Ventilation, COVID-19 Drug Treatment",

author = "Darius Armstrong-James and Jonathan Youngs and Tihana Bicanic and Alireza Abdolrasouli and Denning, \{David W\} and Elizabeth Johnson and Varun Mehra and Tony Pagliuca and Brijesh Patel and Johanna Rhodes and Silke Schelenz and Anand Shah and \{van de Veerdonk\}, \{Frank L\} and Verweij, \{Paul E\} and White, \{P Lewis\} and Fisher, \{Matthew C\}",

year = "2020",

month = oct,

doi = "10.1183/13993003.02554-2020",

language = "English",

volume = "56",

journal = "The European respiratory journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "4",

}

Armstrong-James, D, Youngs, J, Bicanic, T, Abdolrasouli, A, Denning, DW, Johnson, E, Mehra, V, Pagliuca, T, Patel, B, Rhodes, J, Schelenz, S, Shah, A, van de Veerdonk, FL, Verweij, PE, White, PL & Fisher, MC 2020, 'Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis', The European respiratory journal, vol. 56, no. 4. https://doi.org/10.1183/13993003.02554-2020

TY - JOUR

T1 - Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

AU - Armstrong-James, Darius

AU - Youngs, Jonathan

AU - Bicanic, Tihana

AU - Abdolrasouli, Alireza

AU - Denning, David W

AU - Johnson, Elizabeth

AU - Mehra, Varun

AU - Pagliuca, Tony

AU - Patel, Brijesh

AU - Rhodes, Johanna

AU - Schelenz, Silke

AU - Shah, Anand

AU - van de Veerdonk, Frank L

AU - Verweij, Paul E

AU - White, P Lewis

AU - Fisher, Matthew C

PY - 2020/10

Y1 - 2020/10

N2 - Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections https://bit.ly/3feuGsQ

AB - Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections https://bit.ly/3feuGsQ

KW - Adrenal Cortex Hormones/therapeutic use

KW - Antifungal Agents/therapeutic use

KW - Betacoronavirus

KW - Bronchoalveolar Lavage Fluid/microbiology

KW - Bronchoscopy

KW - COVID-19

KW - Coinfection/diagnosis

KW - Coronavirus Infections/drug therapy

KW - Humans

KW - Immunologic Factors/therapeutic use

KW - Intensive Care Units

KW - Invasive Pulmonary Aspergillosis/diagnosis

KW - Pandemics

KW - Pneumonia, Viral/drug therapy

KW - Pulmonary Aspergillosis/diagnosis

KW - Risk Factors

KW - SARS-CoV-2

KW - Ventilation

KW - COVID-19 Drug Treatment

U2 - 10.1183/13993003.02554-2020

DO - 10.1183/13993003.02554-2020

M3 - Article

C2 - 32703771

SN - 0903-1936

VL - 56

JO - The European respiratory journal

JF - The European respiratory journal

IS - 4

ER -

Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis

Abstract

Keywords

Access to Document

Fingerprint

Cite this